feed,title,long_url,short_url
SD,"Licensed drug could reduce SARS-CoV-2 infection by up to 70 per cent, lab study reveals",https://www.sciencedaily.com/releases/2021/08/210806104405.htm,https://j.mp/2VCSQrP
SD,"Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection",https://www.sciencedaily.com/releases/2021/08/210806104337.htm,https://j.mp/3yuqUVZ
